ライフサイエンスコーパス: intraepithelial lesion

1 psy/normal histology and high-grade squamous intraepithelial lesion.

2 n classification of conjunctival melanocytic intraepithelial lesions.

3 in a high proportion of high-grade squamous intraepithelial lesions.

4 women before and after treatment of cervical intraepithelial lesions.

5 sted case-control study of cervical squamous intraepithelial lesions.

6 ed in both low-grade and high-grade squamous intraepithelial lesions.

7 Younger mice had precancerous intraepithelial lesions.

8 -grade (LSIL) and high-grade (HSIL) squamous intraepithelial lesions.

9 raepithelial lesions, or high-grade squamous intraepithelial lesions.

10 d risk of progression to high-grade squamous intraepithelial lesions.

11 40 participants (6%) had high-grade squamous intraepithelial lesions.

12 r all patients with conjunctival melanocytic intraepithelial lesions.

13 .61-1.20) for those with high-grade squamous intraepithelial lesions.

14 I, 2.5%-8.5%; I(2) = 0%) high-grade squamous intraepithelial lesions.

15 ngly associated with detection of a squamous intraepithelial lesions 4-8 months earlier (odds ratio,

16 5 percent of all smears); low-grade squamous intraepithelial lesion, 44 (0.5 percent); high-grade squ

17 esion, 44 (0.5 percent); high-grade squamous intraepithelial lesion, 6 (0.1 percent); and squamous-ce

18 undetermined significance/low-grade squamous intraepithelial lesion (88.4%) or HPV16 was negative (85

19 ted with histologic anal high-grade squamous intraepithelial lesion (A-HSIL) as the dependent variabl

20 Anal high-grade squamous intraepithelial lesion (aHSIL) is the immediate precurso

21 6, and histological anal high-grade squamous intraepithelial lesions (aHSIL) were identified using ad

22 op in patients with anal high-grade squamous intraepithelial lesions (aHSILs) on initial or subsequen

23 Eleven of 33 high-grade squamous intraepithelial lesions and 1 of 12 low-grade squamous i

24 predictor for virally-mediated anal squamous intraepithelial lesions and cancer (anal disease).

25 uld be considered to prevent anal high-grade intraepithelial lesions and cancer caused by anal hrHPV

26 ital (pre)cancers, including anal high-grade intraepithelial lesions and cancer.

27 sible the simultaneous screening of cervical intraepithelial lesions and detection of C. trachomatis

28 selectively in the epithelium of high-grade intraepithelial lesions and in frank cancer.

29 lain the increased risk of cervical squamous intraepithelial lesions and invasive cervical cancer in

30 with the development of high-grade squamous intraepithelial lesions and invasive cervical cancer.

31 nificance (ASC-US) and patients negative for intraepithelial lesions and malignancy (NILM) (P </= 0.0

32 ad a higher frequency of advanced pancreatic intraepithelial lesions and more foci of invasive cancer

33 ed in SCCs compared with high-grade squamous intraepithelial lesions and normal squamous epithelia.

34 ication systems for conjunctival melanocytic intraepithelial lesions and suggests that the simplified

35 termined significance and low-grade squamous intraepithelial lesion) and CIN1+ was also significant.

36 e, and 17.0% had high- or low-grade squamous intraepithelial lesions) and were significantly associat

37 49 participants (24%) had low-grade squamous intraepithelial lesions, and 40 participants (6%) had hi

38 nfection (HPV), low- and high-grade squamous intraepithelial lesions, and cervical cancer stages I-IV

39 intraepithelial lesions, high-grade squamous intraepithelial lesions, and SCC specimens.

40 Genital HPV infection and squamous intraepithelial lesions are common among women who are s

41 Intraepithelial lesions are common early events among wo

42 KPC) mice at 4 weeks of age (when pancreatic intraepithelial lesions are histologically evident).

43 women with ICC, high- and low-grade squamous intraepithelial lesions, as well as, HPV-positive and he

44 Anal squamous intraepithelial lesions (ASIL) or anal intraepithelial n

45 val = 2.4-13.4) more likely to have squamous intraepithelial lesions associated with the detection of

46 d significance [ASCUS] or low-grade squamous intraepithelial lesions) because of an ASCUS Papanicolao

47 eatment of biopsy-proven high-grade squamous intraepithelial lesions (bHSIL) is difficult to implemen

48 Precancerous squamous intraepithelial lesions can be detected by screening, an

49 Cytological high-grade squamous intraepithelial lesions (cHSIL) incidence and clearance

50 women with histologically confirmed cervical intraepithelial lesions (CIN).

51 increased through ASCUS, low-grade squamous intraepithelial lesions, CIN1, and CIN2 (18%-25%), up to

52 Among women with low-grade squamous intraepithelial lesion cytology, HC2 was more likely to

53 ermined significance and high-grade squamous intraepithelial lesion cytology.

54 ions with either CIN2 or high-grade squamous intraepithelial lesion cytology; cluster 3 included olde

55 nknown protective factors that operate after intraepithelial lesions develop.

56 ous cells-cannot exclude high grade squamous intraepithelial lesion) for women who were positive for

57 ed in an upgrade of conjunctival melanocytic intraepithelial lesion from low-grade to high-grade in 2

58 rmal cervical tissues and low-grade squamous intraepithelial lesions from cervical cancers and most o

59 elial lesions and 1 of 12 low-grade squamous intraepithelial lesions had abnormal Fhit expression.

60 tment of anal histologic high-grade squamous intraepithelial lesions (hHSIL) prevents anal cancer.

61 of primary normal cervix, low grade squamous intraepithelial lesions, high-grade squamous intraepithe

62 US) or as cannot exclude high-grade squamous intraepithelial lesion (HSIL) (ASC-H).

63 r a combined endpoint of high-grade squamous intraepithelial lesion (HSIL) and anal intraepithelial n

64 ylation analysis of anal high-grade squamous intraepithelial lesion (HSIL) biopsies was shown to dist

65 PV)-associated precancer high-grade squamous intraepithelial lesion (HSIL) in human immunodeficiency

66 egy for the detection of high-grade squamous intraepithelial lesion (HSIL) or worse.

67 eous progression through high-grade squamous intraepithelial lesion (HSIL) to carcinoma, and (iii) fl

68 e anal cancer precursor, high-grade squamous intraepithelial lesion (HSIL), frequently regresses spon

69 a higher burden of anal high-grade squamous intraepithelial lesions (HSIL) and anal cancer (AC) comp

70 t high risk for cervical high-grade squamous intraepithelial lesions (HSIL) and cervical cancer.

71 t high risk for cervical high-grade squamous intraepithelial lesions (HSIL) and cervical cancer.

72 al HPV16 infection, anal high-grade squamous intraepithelial lesions (HSIL) and, hence, anal cancer.

73 ions (LSIL, n = 14), and high-grade squamous intraepithelial lesions (HSIL) grade 2 (CIN2, n = 8), an

74 gical predictors of anal high-grade squamous intraepithelial lesions (HSIL) in human immunodeficiency

75 papillomavirus (HPV) and high-grade squamous intraepithelial lesions (HSIL) in men can inform anal ca

76 t untreated, a subset of high-grade squamous intraepithelial lesions (HSIL) of the cervix will progre

77 High-grade squamous intraepithelial lesions (HSIL) or cervical intraepitheli

78 lesions (LSIL), 21 with high-grade squamous intraepithelial lesions (HSIL), and 28 with invasive cer

79 lial neoplasia (CIN2-3), high-grade squamous intraepithelial lesions (HSIL), and invasive cervical ca

80 in low-grade (LSIL) and high-grade squamous intraepithelial lesions (HSIL), and the AIN classificati

81 y of its precursor, anal high-grade squamous intraepithelial lesions (HSIL).

82 high and high-threshold (high-grade squamous intraepithelial lesion [HSIL] on cytology) if availabili

83 -grade lesion [ASC-H] or high-grade squamous intraepithelial lesion [HSIL] with positive HPV test res

84 ng premalignant lesions (high-grade squamous intraepithelial lesions [HSIL]) associated with anal can

85 tances, women with ASC-H, low-grade squamous intraepithelial lesion, HSIL, and atypical glandular cel

86 Anal high-grade squamous intraepithelial lesions (HSILs) ablation may reduce the

87 s can cause preinvasive, high-grade squamous intraepithelial lesions (HSILs) as precursors to cancer

88 low-grade and 1282 with high-grade squamous intraepithelial lesions (HSILs) diagnosed cytologically;

89 and determinants of anal high-grade squamous intraepithelial lesions (HSILs) in men who have sex with

90 vestigated the prevalence of anal high-grade intraepithelial lesions (HSILs) in RTRs compared with im

91 re than one third of the high-grade squamous intraepithelial lesions (HSILs) in screening populations

92 Anal high-grade squamous intraepithelial lesions (HSILs) precede anal cancer, and

93 e anal cancer precursor, high-grade squamous intraepithelial lesions (HSILs), among young MSM with HI

94 cancers and most of the high-grade squamous intraepithelial lesions (HSILs).

95 us (HPV)-associated anal high-grade squamous intraepithelial lesions (HSILs).

96 al cancer is preceded by high-grade squamous intraepithelial lesions (HSILs).

97 associated with risk of high-grade squamous intraepithelial lesions (HSILs).

98 focal intra-anal tissue high-grade squamous intraepithelial lesions (HSILs).

99 nvasive cervical cancer, high-grade squamous intraepithelial lesions (HSILs; n=166), or low-grade squ

100 oncurrent with cytologic high grade squamous intraepithelial lesions [HSILs]).

101 vical cancer precursors (high-grade squamous intraepithelial lesions [HSILs]).

102 rs and/or progression to high-grade squamous intraepithelial lesions (ie, cervical intraepithelial ne

103 en, HPV DNA was detected in 19% and squamous intraepithelial lesions in 14%.

104 explain the increased incidence of squamous intraepithelial lesions in HIV-seropositive women.

105 AS mutations, and reliably detect pancreatic intraepithelial lesions in mice despite negative signals

106 he detection of low- and high-grade squamous intraepithelial lesions in Papanicolaou test whole-slide

107 -grade (LSIL) and high grade (HSIL) squamous intraepithelial lesions, in the cervix and anus.

108 cells, cannot exclude a high-grade squamous intraepithelial lesion, low-grade squamous intraepitheli

109 significance (ASCUS) and low-grade squamous intraepithelial lesion (LSIL) triage study (ALTS), who w

110 HPV test, and persistent low-grade squamous intraepithelial lesion (LSIL) were significantly associa

111 HIV-infected women with a low-grade squamous intraepithelial lesion (LSIL; benchmark indication for c

112 -16) can lead to low- or high-grade squamous intraepithelial lesions (LSIL or HSIL).

113 significance (ASC-US) or low-grade squamous intraepithelial lesions (LSIL) who were triaged with tes

114 significance (ASC-US) or low-grade squamous intraepithelial lesions (LSIL) who were triaged with tes

115 d 66 women diagnosed with low-grade squamous intraepithelial lesions (LSIL), 21 with high-grade squam

116 including normal cervix, low-grade squamous intraepithelial lesions (LSIL), high-grade SILs (HSIL),

117 amous cells (ASC, n = 5), low-grade squamous intraepithelial lesions (LSIL, n = 14), and high-grade s

118 significance [ASC-US] or low-grade squamous intraepithelial lesion [LSIL]) and a positive HPV test o

119 n about the prevalence of low-grade squamous intraepithelial lesions (LSILs) and the anal cancer prec

120 Low-grade squamous intraepithelial lesions (LSILs) have been described as a

121 ned significance (ASCUS), low-grade squamous intraepithelial lesions (LSILs), and high-grade SILs (HS

122 esions (HSILs; n=166), or low-grade squamous intraepithelial lesions (LSILs); were positive for human

123 38%) and high-grade conjunctival melanocytic intraepithelial lesion/melanoma in situ (n = 29, 62%).

124 rs most predictive of high-grade melanocytic intraepithelial lesion/melanoma in situ were involvement

125 oses were low-grade conjunctival melanocytic intraepithelial lesion (n = 18, 38%) and high-grade conj

126 ble analysis, a history of cervical squamous intraepithelial lesion (odds ratio [OR], 4.2; 95% confid

127 al precancer, defined as high-grade squamous intraepithelial lesions of the cervix.

128 In SA, cytology high-grade squamous intraepithelial lesion or greater (HSIL+) had best combi

129 -16/18 genotype HPV results and negative for intraepithelial lesion or malignancy (NILM) cytological

130 HPV16, HPV18, or both or low-grade squamous intraepithelial lesion or worse cytology had better sens

131 HPV16, HPV18, or both or high-grade squamous intraepithelial lesion or worse cytology had higher sens

132 iopsy-confirmed high-grade cervical squamous intraepithelial lesions or invasive cancer.

133 rs from patients with specimens negative for intraepithelial lesions or malignancy (NILM), and low-gr

134 s intraepithelial lesion, low-grade squamous intraepithelial lesions, or high-grade squamous intraepi

135 current high-grade CIN2+/high-grade squamous intraepithelial lesions post-treatment.

136 maging (BLI), we discovered that microscopic intraepithelial lesions precede the onset of peripheral

137 High-grade squamous intraepithelial lesion prevalence was similar during fir

138 sponses have a protective effect in squamous intraepithelial lesion (SIL) development.

139 Local cervical treatment for squamous intraepithelial lesion (SIL) or cervical intraepithelial

140 outcomes: high-risk HPV prevalence; squamous intraepithelial lesion (SIL) or cervical intraepithelial

141 cytologic evidence of a high-grade squamous intraepithelial lesion (SIL) were referred for colposcop

142 h MY09/MY11/HMB01 HPV primers), and squamous intraepithelial lesions (SIL) (by cytological examinatio

143 ions, abnormal cervical smears, and squamous intraepithelial lesions (SIL) among women with systemic

144 gn (88%) and precancerous (92%) HPV squamous intraepithelial lesions (SIL) and colocalized to cells i

145 orted to be 1.2-83.3% for low-grade squamous intraepithelial lesions (SIL) and to be 13.3-83.3% for h

146 en human papillomavirus (HPV), anal squamous intraepithelial lesions (SIL), and human immunodeficienc

147 ural history of the precursor, anal squamous intraepithelial lesions (SIL), are limited.

148 Screening methods for anal squamous intraepithelial lesions (SILs) are suboptimal.

149 A (retinol) deficiency and cervical squamous intraepithelial lesions (SILs) in human immunodeficiency

150 commonly associated with low-grade squamous intraepithelial lesions (SILs) were 56 and 53.

151 ults, defined as at least low-grade squamous intraepithelial lesions (SILs), in 774 human immunodefic

152 are at increased risk for cervical squamous intraepithelial lesions (SILs), the precursors to invasi

153 al and 97 specimens from women with squamous intraepithelial lesions (SILs).

154 e precursor to this carcinoma, anal squamous intraepithelial lesions (SILs).

155 RT) on HPV persistence and cervical squamous intraepithelial lesions (SILs).

156 (by polymerase chain reaction) and squamous intraepithelial lesions (SILs).

157 ion have a higher risk for cervical squamous intraepithelial lesions than do women without HIV infect

158 d SOX10 facilitate assessment of melanocytic intraepithelial lesions, the current immunohistochemical

159 e lesions progressed from low-grade squamous intraepithelial lesions to HSILs and finally to cancer.

160 of human papillomavirus-associated squamous intraepithelial lesions to invasive cervical cancer is p

161 preventing the progression of preneoplastic intraepithelial lesions to invasive pancreatic ductal ad

162 ancies in TRAMP mice progress from precursor intraepithelial lesions, to invasive carcinoma that meta

163 undetermined significance-low-grade squamous intraepithelial lesion triage study (ALTS).

164 Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS, 1997-2001), t

165 Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study provided blood sampl

166 termined Significance and Low-Grade Squamous Intraepithelial Lesion Triage Study who were treated for

167 undetermined significance-low-grade squamous intraepithelial lesion triage study with the use of unsu

168 termined Significance and Low-Grade Squamous Intraepithelial Lesion Triage Study, in which women were

169 Significance (ASCUS) and Low-Grade Squamous Intraepithelial Lesion Triage Study.

170 Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS), we determin

171 Undetermined Significance-Low-Grade Squamous Intraepithelial Lesion) Triage Study and who returned 1

172 pooled prevalence estimate of anal squamous intraepithelial lesions was 22.4% (95% CI, 17.3%-28.5%;

173 n elevated risk for high-grade anal squamous intraepithelial lesions was associated with infection by

174 The prevalence of high-grade squamous intraepithelial lesions was strongly related to oncogeni

175 ease (ie, CIN 2 or 3, or high-grade squamous intraepithelial lesion) was 6.09 (3.87-9.60) compared wi

176 seases, compared with the risk of developing intraepithelial lesions, was not related to any of a lar

177 use by their partners, no cervical squamous intraepithelial lesions were detected in 32 patient-year

178 High-grade squamous intraepithelial lesions were identified in 47 (3.4%) of

179 Squamous intraepithelial lesions were present in 15% (17/16) of H

180 V-infected men with high-grade anal squamous intraepithelial lesions were significantly more likely t

181 on and progression rates of HPV and squamous intraepithelial lesions, were obtained from the literatu

182 in HPV-positive cervical high-grade squamous intraepithelial lesions when compared with normal cervic

183 termined significance and low-grade squamous intraepithelial lesions who are at higher and lower risk

184 untreated, some cervical high-grade squamous intraepithelial lesions will progress to invasive squamo

185 ication systems for conjunctival melanocytic intraepithelial lesions with the new World Health Organi

186 ng the pathological features of higher-grade intraepithelial lesions, yet did not exhibit chromosomal